Holen Sie sich die Stockscreener-App
3.14
2.79%
-0.09
Schlusskurs vom Vortag:
$3.23
Offen:
$3.24
24-Stunden-Volumen:
453.18K
Relative Volume:
0.61
Marktkapitalisierung:
$220.97M
Einnahmen:
$299.48M
Nettoeinkommen (Verlust:
$-86.45M
KGV:
-2.0933
EPS:
-1.5
Netto-Cashflow:
$-17.32M
1W Leistung:
-9.25%
1M Leistung:
+6.08%
6M Leistung:
-25.06%
1J Leistung:
-59.22%
1-Tages-Spanne:
$3.035
$3.36
1-Wochen-Bereich:
$3.035
$3.615
52-Wochen-Spanne:
$2.515
$9.24
Health Catalyst Inc Stock (HCAT) Company Profile
Firmenname
Health Catalyst Inc
Sektor
Branche
Telefon
801-708-6800
Adresse
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Vergleichen Sie HCAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
3.14 | 227.31M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
292.72 | 47.73B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
88.71 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.95 | 12.36B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.81 | 8.15B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.03 | 6.86B | 906.14M | -52.62M | 89.62M | -0.3621 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-08 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2024-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-05-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Eingeleitet | Stephens | Equal-Weight |
| 2023-04-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-10-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Herabstufung | Stifel | Buy → Hold |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-03-17 | Hochstufung | Jefferies | Hold → Buy |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-10-14 | Eingeleitet | BTIG Research | Buy |
| 2021-04-29 | Fortgesetzt | JP Morgan | Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-07-14 | Eingeleitet | Citigroup | Buy |
| 2020-06-18 | Eingeleitet | Stifel | Buy |
| 2020-06-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-05-15 | Eingeleitet | Guggenheim | Buy |
| 2020-04-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-04-13 | Eingeleitet | SVB Leerink | Outperform |
| 2020-04-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-20 | Eingeleitet | Raymond James | Strong Buy |
| 2019-10-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Eingeleitet | Evercore ISI | Outperform |
| 2019-08-19 | Eingeleitet | Goldman | Buy |
| 2019-08-19 | Eingeleitet | JP Morgan | Overweight |
| 2019-08-19 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-19 | Eingeleitet | SunTrust | Buy |
| 2019-08-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Health Catalyst Inc Aktie (HCAT) Neueste Nachrichten
Is Health Catalyst Inc. still worth holding after the dip2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Will earnings trigger a reversal in Health Catalyst Inc.July 2025 Action & Weekly Top Stock Performers List - newser.com
Building trade automation scripts for Health Catalyst Inc.July 2025 Drop Watch & Capital Protection Trading Alerts - newser.com
Palogic Value Management L.P. Has $2.75 Million Stock Holdings in Health Catalyst, Inc. $HCAT - MarketBeat
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumForecast Cut & Weekly Consistent Profit Watchlists - newser.com
What does recent volatility data suggest for Health Catalyst Inc.Quarterly Risk Review & Real-Time Volume Trigger Notifications - newser.com
Will Health Catalyst Inc. stock gain from lower inflationGold Moves & Capital Efficiency Focused Strategies - newser.com
Why Health Catalyst Inc. stock could benefit from AI revolutionAnalyst Upgrade & Weekly High Conviction Ideas - newser.com
Understanding Health Catalyst Inc.’s price movementJuly 2025 Recap & Verified Swing Trading Watchlist - newser.com
Is Health Catalyst Inc. (2YP) stock vulnerable to rate hikesMarket Rally & Verified Chart Pattern Signals - newser.com
What indicators show strength in Health Catalyst Inc.2025 Top Gainers & Expert Curated Trade Setups - newser.com
Live market analysis of Health Catalyst Inc.Weekly Investment Report & AI Based Buy and Sell Signals - newser.com
Is Health Catalyst Inc. (2YP) stock worth holding before Fed meetingEntry Point & Risk Managed Investment Signals - newser.com
Is Health Catalyst Inc. stock affected by interest rate hikesWeekly Trend Summary & Long-Term Capital Growth Ideas - newser.com
Will Health Catalyst Inc. stock benefit from green energy trends2025 Market Outlook & Daily Stock Momentum Reports - newser.com
Is Health Catalyst Inc. meeting your algorithmic filter criteriaWeekly Loss Report & Reliable Trade Execution Plans - newser.com
Health Catalyst Inc. stock trend outlook and recovery pathJuly 2025 Earnings & Safe Swing Trade Setups - newser.com
Quantitative breakdown of Health Catalyst Inc. recent moveGold Moves & Risk Managed Investment Signals - newser.com
Will Health Catalyst Inc. (2YP) stock hit Wall Street targets2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
AMH Equity Ltd Purchases 174,649 Shares of Health Catalyst, Inc. $HCAT - MarketBeat
Can Health Catalyst Inc. stock beat market expectations this quarterWeekly Profit Summary & AI Powered Trade Plan Recommendations - newser.com
Backtesting results for Health Catalyst Inc. trading strategies2025 Dividend Review & Short-Term High Return Ideas - newser.com
How to build a dashboard for Health Catalyst Inc. stockGlobal Markets & Real-Time Stock Entry Alerts - newser.com
Finanzdaten der Health Catalyst Inc-Aktie (HCAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
8.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):